Up next

Autoplay

Acute Lymphoblastic Leukemia: Optimizing MRD Testing

0 Views • 06/15/23
Share
Embed
administrator
administrator
Subscribers
0

Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; and Bijal D. Shah, MD, reflect on the optimal time to test for minimal residual disease and how to best interpret the results regarding the prognosis of a patient with acute lymphoblastic leukemia.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay